Skip navigation

Publications – Shane M. Pearce

1. Nazemi A, Ghodoussipour S, Pearce, S.M., Bhanvadia S, Daneshmand S. Socioeconomic and insurance status
are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer.
Urol Oncol. 2019 May 8. pii: S1078-1439(19)30154-1. doi: 10.1016/j.urolonc.2019.04.021. [Epub ahead
of print]
2. Nazemi A, Nassiri N, Pearce, S.M., Daneshmand S. Testicular Mesothelioma: An Analysis of Epidemiology,
Patient Outcomes and Prognostic Factors. Urology. 2019 (In press).
3. Lin-Brande M, Nazemi A, Pearce, S.M., Thompson ER, Ashrafi AN, Djaladat H, Schuckman A, Daneshmand S.
Assessing Trends in Urinary Diversion after Radical Cystectomy for Bladder Cancer in the United
States. Urol Oncol. 2019 Mar;37(3): 180.e1-180. e9.
4. Bateni ZH, Pearce, S.M., Zainfeld D, Ballas L, Djaladat H, Schuckman AK, Daneshmand S. National
Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for
Urothelial Bladder Cancer in the USA, 2004–2013. European Urology Oncology (In press).
5. Pearce, S.M., Daneshmand S. Enhanced Endoscopy in Bladder Cancer. Curr Urol Rep. 2018 Aug 17;19(10):84.
6. Werntz RP, Pearce, S.M., Eggener SE. Indications, Evolving Technique and Early Outcomes with Robotic
Retroperitoneal Lymph Node Dissection. Curr Opin Urol. 2018 Sep;28(5):461-468.
7. Barashi NS, Pearce, S.M., Cohen AJ, Pariser JJ, Packiam VT, Eggener SE. Incidence, Risk Factors, and
Outcomes for Rectal Injury During Radical Prostatectomy: A Population-based Study. European Urology
Oncology 2018. (In press)
8. Johnson SC, Smith ZL, Golan S, Rodriguez JF 3rd, Pearce, S.M., Smith ND, Steinberg GD. Perioperative
and Long-term Outcomes After Radical Cystectomy in Hemodialysis Patients. Urol Oncol. 2018 Jan 21.
9. Pearce, S.M., Daneshmand S. Continent Cutaneous Diversion. Urol Clin North Am. 2018 Feb;45(1):55-65.
10. Tallman JE, Pearce, S.M., Kuchta K, Helfand BT, Eggener SE. Impact of Perioperative Infection on
Cancer-Specific Survival after Nephrectomy for Renal Cell Carcinoma. J Urol. 2017
11. Wymer KM, Daneshmand S, Pierorazio PM, Pearce, S.M., Harris KT, Eggener SE. Mildly Elevated Serum
Alpha-Fetoprotein (AFP) Among Patients with Testicular Cancer May Not Be Associated with Residual
Cancer or Need for Treatment. Ann Oncol. 2017 Apr 1;28(4):899-902.
12. Wymer KM, Pearce, S.M., Harris KT, Pierorazio PM, Daneshmand S, Eggener SE. Adherence to the National
Comprehensive Cancer Network Guidelines for Testicular Cancer. J Urol. 2017 Mar;197(3 Pt 1):684-689.
13. Weiner AB, Pearce, S.M., Eggener SE. Management Trends for Men with Early-Stage Nonseminomatous Germ
Cell Tumors of the Testicle: An Analysis of the National Cancer Database. Cancer. 2017 Jan
14. Pariser JJ, Pearce, S.M., Anderson BB, Packiam VT, Prachand VN, Smith ND, Steinberg GD. Extended
Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy
Compared to Inpatient Only Subcutaneous Heparin. J Urol. 2017 Feb;197(2):302-307.
15. Packiam VT, Agrawal VA, Pariser JJ, Cohen AJ, Nottingham CU, Pearce, S.M., Smith ND, Steinberg GD.
Redefining the Implications of Nasogastic Tube Placement Following Radical Cystectomy in the
Alvimopan Era. World J Uro. 2016 Jul 30. [Epub]
16. Choy B, Pearce, S.M., Anderson BB, Shalhav AL, Zagaja G, Eggener SE, Paner GP. Prognostic Significance
of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical
Prostatectomy. Am J Surg Pathol. 2016 Oct;40(10):1400-6.
17. Gundeti MS, Petravick ME, Pariser JJ, Pearce, S.M., Anderson BB, Grimsby GM, Akhavan A, Dangle PP,
Shukla AR, Lendvay TS, Cannon GM Jr, Gargollo PC. A Multi-Institutional Study of Perioperative
Functional Outcomes for Pediatric Robotic-Assisted Laparoscopic Appendicovesicostomy.
18. Packiam VT, Nottingham CU, Cohen AJ, Pearce, S.M., Shalhav AL, Eggener SE. The Impact of Perioperative
Aspirin on Bleeding Complications Following Robotic Partial Nephrectomy. J Endourol. 2016
19. Pearce, S.M., Gorin MA, Luckenbaugh AN, Montgomery JS, Hafez KS, Weizer AZ, Pierorazio PM, Allaf ME,
Porter JR, Eggener SE. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal
Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Eur Urol. 2017
20. Pearce, S.M., Pariser JJ, Malik RD, Famakinwa OJ, Chung DE. Safety and Outcomes Following Thulium
Vapoenucleation of Large Prostates. Int Braz J Urol. 2016 Jul-Aug;42(4)302-307.
21. Reddy AV, Pariser JJ, Pearce, S.M., Weichselbaum RR, Smith ND, Steinberg GD, Liauw SL. Patterns of
failure after radical cystectomy for pT3-4 bladder cancer: Implications for adjuvant radiation
therapy. Int J Radiat Oncol. 2016 Apr 1;94(5):1031-9.
22. Pearce, S.M., Rao P, Thomas S, Eggener SE. Nonneoplastic Disease Presenting as a Renal Lesion. In:
Hansel ED, Kane JC, Paner PG, Chang SS, editors. The Kidney: A Comprehensive Guide to Pathologic
Diagnosis and Management. New York, NY: Springer New York; 2016. p. 37–51.
23. Anderson BB, Pariser JJ, Pearce, S.M., Volsky J, Bales GT, Chung DE. Safety and Efficacy of Retropubic
Mid-Urethral Sling Placement in Women Who Void with Valsalva. Urology. 2016 Feb 12. pii:
24. Pearce, S.M., Pariser JJ, Karrison T, Patel SG, Eggener SE. Comparison of Perioperative and Early
Oncologic Outcomes Between Open and Robotic-Assisted Laparoscopic Prostatectomy in a Contemporary
Population-Based Cohort. J Urol. 2016 Feb 6. pii: S0022-5347(16)00240-8.
25. Packiam VT, Pearce, S.M., Steinberg GD. The role of mycobacterial cell wall nucleic acid complex in the
treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancer. Ther Adv
Urol. 2016 Feb; 8(1):29-37.
26. Pariser JJ, Anderson BB, Pearce, S.M., Han Z, Rodriguez JA 3rd, Landon E, Pisano JC, Smith ND,
Steinberg GD. The effect of broader, directed antimicrobial prophylaxis including fungal coverage on
perioperative infectious complications after radical cystectomy. Urol Oncol. 2016
27. Pearce, S.M., Pariser JJ, Patel SG, Steinberg GD, Shalhav AL, Smith ND. The effect of surgical approach
on performance of lymphadenectomy and perioperative morbidity for radical nephroureterectomy. Urol
Oncol. 2015 Oct 19. pii: S1078-1439(15)00451-2.
28. Pearce, S.M., Wang CH, Victorson DE, Helfand BT, Novakovic KR, Brendler CB, Albaugh JA. A Longitudinal
Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer. Sex
Med. 2015 Sep;3(3):156-64.
29. Pariser JJ, Pearce, S.M., Patel SG, Bales GT. National Trends of Simple Prostatectomy for Benign
Prostatic Hyperplasia With an Analysis of Risk Factors for Adverse Perioperative Outcomes. Urology.
2015 Oct;86(4):721-6.
30. Pariser JJ, Pearce, S.M., Patel SG, Bales GT. Reply. Urology. 2015 Oct;86(4):726.
31. Pearce, S.M., Liauw SL, Eggener SE. Management of Low-Stage Testicular Seminoma. Urol Clin North Am.
2015 Aug;42(3):287-98.
32. Pariser JJ, Pearce, S.M., Patel SG, Bales GT. National Patterns of Urethral Evaluation and Risk Factors
for Urethral Injury in Patients With Penile Fracture. Urology. 2015 Jul;86(1):181-5.
33. Pariser JJ, Pearce, S.M., Patel SG, Bales GT. Reply: To PMID 26142603. Urology. 2015 Jul;86(1):186.
34. Pariser JJ, Pearce, S.M., Patel SG, Anderson BB, Packiam VT, Shalhav AL, Bales GT, Smith ND.
Rhabdomyolysis After Major Urologic Surgery: Epidemiology, Risk Factors, and Outcomes. Urology. 2015
35. Pearce, S.M., Pariser JJ, Patel SG, Anderson BB, Eggener SE, Zagaja GP. The impact of days off between
cases on perioperative outcomes for robotic-assisted laparoscopic prostatectomy. World J Urol. 2015
Jun 5. [Epub ahead of print]
36. Pearce, S.M., Eggener SE. Cystic Lesion of the Prostate. AUA News. 2015 Jan;20(1): 8,20.
37. Pearce, S.M., Richards KA, Patel SG, Pariser JJ, Eggener SE. Population-Based Analysis of Salvage
Radical Prostatectomy with Examination of Factors Associated with Adverse Perioperative Outcomes.
Urol Oncol. 2015 Apr;33(4):163.e1-6.
38. Cohen AJ, Pariser JJ, Anderson BB, Pearce, S.M., Gundeti MS. The Robotic Appendicovesicostomy and
Bladder Augmentation: the next frontier in robotics, are we there? Urol Clin North Am. 2015 Feb;
39. Pearce, S.M., Cohn JA, Steinberg Z, Steinberg GD. Patient Selection, Operative Technique, and
Contemporary Outcomes of Continent Catheterizable Diversion: the Indiana Pouch. Curr Bladder
Dysfunct Rep. 2014 Sep 14;9(4):293–301.
40. Pariser JJ, Famakinwa OJ, Pearce, S.M., Chung DE. High-Power Thulium Laser Vaporization of the
Prostate: Short-term Outcomes of Safety and Effectiveness. J Endourol. 2014 Nov;28(11):1357-62.
41. Pearce, S.M., Steinberg Z, Eggener S. Critical evaluation of modified templates and current trends in
retroperitoneal lymph node dissection. Curr Urol Rep. 2013 Oct;14(5):511-7.
42. Ahmed MM, King KC, Pearce, S.M., Ramsey MA, Miranpuri GS, Resnick DK. Novel Target for Spinal Cord
Injury Neuropathic Pain. Mini Rev Med Chem. 2012 Feb 1.
43. Huang HS, Pyeon D, Pearce, S.M., Lank SM, Griffin LM, Ahlquist P, Lambert PF. Novel antivirals inhibit
early steps in HPV infection. Antiviral Res. 93(2):280-7, 2012 Feb.
44. Pyeon D, Pearce, S.M., Lank SM, Ahlquist P, and Lambert PF. Establishment of Human Papillomavirus
Infection Requires Cell Cycle Progression. PLoS Pathog., 5(2):e1000318, 2009.
45. Pearce, S.M., Ramsey, MA, Miranpuri GS, Resnick, D. Regulation and function of matrix
metalloproteinases in nervous system injury and neuropathic pain. Annals of Neurosciences, 15(4),